Advanced
  Home Compare Reports

Comparison with Similar Reports

Pen Needles Market by Type (Standard Pen Needles, Safety Pen Needles), Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP 1, Growth Hormon...

Publisher:        MarketsandMarkets

# of Pages:        217

Rating: 

1 User License $4,950

Publication Date:  June, 2021

Price:       $4,950 / User License




1 INTRODUCTION 27
1.1 OBJECTIVES OF THE STUDY 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 27
1.2.2 MARKET SEGMENTATION 28
1.2.3 YEARS CONSIDERED FOR THE STUDY 29
1.3 CURRENCY 29
1.3.1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 29
1.4 LIMITATIONS 30
1.5 STAKEHOLDERS 30
1.6 SUMMARY OF CHANGES 30
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 34
2.1.2 PRIMARY DATA 34
FIGURE 2 PRIMARY SOURCES 34
2.1.2.1 Key data from primary sources 35
2.1.2.2 Key industry insights 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (PEN NEEDLES MARKET) 37
2.2 MARKET SIZE ESTIMATION 37
FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 38
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: BECTON, DICKINSON AND COMPANY (2020) 38
FIGURE 7 REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PEN NEEDLES MARKET (2020) 39
FIGURE 8 DEMAND-SIDE ANALYSIS 40
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 10 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PEN NEEDLES MARKET
(2021–2026) 41
FIGURE 11 TOP-DOWN APPROACH 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 43
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY 43
2.4 MARKET SHARE ANALYSIS 43
2.5 ASSUMPTIONS FOR THE STUDY 44
2.6 RISK ASSESSMENT 44
TABLE 1 RISK ASSESSMENT: PEN NEEDLES MARKET 44
3 EXECUTIVE SUMMARY 45
FIGURE 13 PEN NEEDLES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 45
FIGURE 14 PEN NEEDLES MARKET, BY LENGTH, 2021 VS. 2026 (USD MILLION) 46
FIGURE 15 PEN NEEDLES MARKET, BY THERAPY, 2021 VS. 2026 (USD MILLION) 46
FIGURE 16 PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2021 VS. 2026 (USD MILLION) 47
FIGURE 17 GEOGRAPHIC SNAPSHOT: PEN NEEDLES MARKET 47
4 PREMIUM INSIGHTS 49
4.1 PEN NEEDLES MARKET OVERVIEW 49
FIGURE 18 GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE GROWTH OF THE PEN NEEDLES MARKET 49
4.2 ASIA PACIFIC: PEN NEEDLES MARKET, BY THERAPY AND COUNTRY 50
FIGURE 19 JAPAN DOMINATES THE APAC MARKET 50
4.3 PEN NEEDLES MARKET: GEOGRAPHIC MIX 51
FIGURE 20 INDIA & CHINA TO WITNESS THE HIGHEST GROWTH IN THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 21 PEN NEEDLES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
5.2.1 DRIVERS 53
5.2.1.1 Growing prevalence of chronic diseases 53
FIGURE 22 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS IN THE US,
1995–2030 (MILLION INDIVIDUALS) 53
FIGURE 23 ESTIMATED DIABETIC POPULATION, BY REGION, 2019 VS. 2030 VS. 2040 54
5.2.1.2 Favorable reimbursement in select countries 54
5.2.2 RESTRAINTS 54
5.2.2.1 Preference for alternative modes of drug delivery 54
5.2.2.2 Poor reimbursement scenario in developing countries 55
5.2.2.3 Needle anxiety 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Growing preference for biosimilar drugs 55
5.2.3.2 Emerging markets 56
TABLE 2 RISING INCOME LEVELS IN EMERGING COUNTRIES 56
5.2.4 CHALLENGES 56
5.2.4.1 Reuse of pen needles 56
5.2.4.2 Misuse of injection pens 57
5.3 PRICING ANALYSIS 57
TABLE 3 PRICING OF PEN NEEDLES AVAILABLE IN THE MARKET 58
5.4 VALUE CHAIN ANALYSIS 59
FIGURE 24 PEN NEEDLES MARKET: VALUE CHAIN ANALYSIS 59
5.5 ECOSYSTEM MARKET MAP 59
FIGURE 25 PEN NEEDLES MARKET: ECOSYSTEM MARKET MAP 60
5.6 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 4 PEN NEEDLES MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 60
5.6.2 BARGAINING POWER OF SUPPLIERS 61
5.6.3 BARGAINING POWER OF BUYERS 61
5.6.4 THREAT OF SUBSTITUTES 61
5.6.5 THREAT OF NEW ENTRANTS 62
5.7 SUPPLY CHAIN ANALYSIS 62
FIGURE 26 PEN NEEDLES MARKET: SUPPLY CHAIN ANALYSIS 63
5.8 REGULATORY ANALYSIS 64
5.8.1 NORTH AMERICA 64
5.8.1.1 US 64
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION 64
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 64
5.8.1.2 Canada 64
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 65
FIGURE 27 CANADA: CLASS II MEDICAL DEVICE APPROVAL PROCESS 65
5.8.2 EUROPE 65
FIGURE 28 EUROPE: CE APPROVAL PROCESS FOR CLASS IIA MEDICAL DEVICES 66
5.8.3 ASIA PACIFIC 66
5.8.3.1 Japan 66
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 66
5.8.3.2 China 67
TABLE 9 CHINA: REGULATORY BODIES APPOINTED FOR MEDICAL DEVICE APPROVAL 67
TABLE 10 CHINA: CLASSIFICATION OF MEDICAL DEVICES 67
5.8.3.3 India 68
5.9 IMPACT OF COVID-19 ON THE PEN NEEDLES MARKET 68
5.10 PATENT ANALYSIS 69
5.10.1 PATENT PUBLICATION TRENDS FOR PEN NEEDLES 69
FIGURE 29 PATENT PUBLICATION TRENDS (2011–MAY 2021) 69
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 69
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR PEN NEEDLES PATENTS (JANUARY 2011–JUNE 2021) 70
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR PEN NEEDLE PATENTS (JANUARY 2011–JUNE 2021) 71
5.11 TECHNOLOGY ANALYSIS 71
5.11.1 KEY TECHNOLOGY 71
5.11.1.1 Fluid flow enhancement technology 71
5.11.2 COMPLEMENTARY TECHNOLOGY 71
5.11.2.1 Microfabricated needles 71
5.11.3 ADJACENT TECHNOLOGY 72
5.11.3.1 Autoinjectors 72
6 PEN NEEDLES MARKET, BY TYPE 73
6.1 INTRODUCTION 74
TABLE 11 PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 74
TABLE 12 PEN NEEDLES MARKET, BY TYPE, 2019–2026 (MILLION UNITS) 74
6.2 STANDARD PEN NEEDLES 74
6.2.1 STANDARD PEN NEEDLES ARE PREFERRED OVER SAFETY PEN NEEDLES AS THEY ARE MORE AFFORDABLE 74
TABLE 13 STANDARD PEN NEEDLES OFFERED BY KEY PLAYERS 75
TABLE 14 STANDARD PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 76
TABLE 15 STANDARD PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (MILLION UNITS) 77
6.3 SAFETY PEN NEEDLES 77
6.3.1 GROWING CONCERN OVER NEEDLESTICK INJURIES DRIVES THE GROWTH OF SAFETY PEN NEEDLES 77
TABLE 16 SAFETY PEN NEEDLES OFFERED BY KEY PLAYERS 78
TABLE 17 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 78
TABLE 18 SAFETY PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (MILLION UNITS) 79
7 PEN NEEDLES MARKET, BY LENGTH 80
7.1 INTRODUCTION 81
TABLE 19 PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 81
7.2 8MM 81
7.2.1 8MM PEN NEEDLES WILL CONTINUE TO DOMINATE THE PEN NEEDLES MARKET DURING THE FORECAST PERIOD 81
TABLE 20 8MM PEN NEEDLES OFFERED BY KEY PLAYERS 81
TABLE 21 8MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 82
7.3 5MM 83
7.3.1 5MM PEN NEEDLES TO REGISTER SECOND-HIGHEST GROWTH RATE DURING THE STUDY PERIOD 83
TABLE 22 5MM PEN NEEDLES OFFERED BY KEY PLAYERS 83
TABLE 23 5MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 84
7.4 6MM 84
7.4.1 6MM PEN NEEDLES ARE THE MOST COMMONLY USED NEEDLES ACROSS THE GLOBE 84
TABLE 24 6MM PEN NEEDLES OFFERED BY KEY PLAYERS 85
TABLE 25 6MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 86
7.5 4MM 86
7.5.1 4MM PEN NEEDLES ARE EXPECTED TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 86
TABLE 26 4MM PEN NEEDLES OFFERED BY KEY PLAYERS 86
TABLE 27 4MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 87
7.6 12MM 88
7.6.1 THE POPULARITY OF SHORTER & LESS PAINFUL NEEDLES HAMPERS THE GROWTH OF THE 12MM PEN NEEDLES MARKET 88
TABLE 28 12MM PEN NEEDLES OFFERED BY KEY PLAYERS 88
TABLE 29 12MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 89
7.7 10MM 89
7.7.1 AVAILABILITY OF SHORTER PEN NEEDLES TO RESTRAIN THE GROWTH OF THE 10MM PEN NEEDLES MARKET 89
TABLE 30 10MM PEN NEEDLES OFFERED BY KEY PLAYERS 89
TABLE 31 10MM PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 90
8 PEN NEEDLES MARKET, BY THERAPY 91
8.1 INTRODUCTION 92
TABLE 32 PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 92
8.2 INSULIN THERAPY 92
8.2.1 RISING PREVALENCE OF DIABETES DRIVES THE GROWTH OF THE PEN NEEDLES MARKET FOR INSULIN THERAPY 92
TABLE 33 PEN NEEDLES MARKET FOR INSULIN THERAPY, BY COUNTRY,
2019–2026 (USD MILLION) 93
8.3 GLUCAGON-LIKE PEPTIDE-1 THERAPY 93
8.3.1 STRONG FOCUS OF MAJOR PHARMACEUTICAL COMPANIES TO INTRODUCE GLP-1 DRUGS TO DRIVE MARKET GROWTH 93
TABLE 34 PEN NEEDLES MARKET FOR GLP-1 THERAPY, BY COUNTRY,
2019–2026 (USD MILLION) 94
8.4 GROWTH HORMONE THERAPY 95
8.4.1 DEVELOPMENT OF SUSTAINED-RELEASE GROWTH HORMONE FORMULATIONS FOR REDUCING INJECTION FREQUENCY TO RESTRAIN THE GROWTH OF THE PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY 95
TABLE 35 PEN NEEDLES MARKET FOR GROWTH HORMONE THERAPY, BY COUNTRY, 2019–2026 (USD MILLION) 96
8.5 OTHER THERAPIES 96
TABLE 36 PEN NEEDLES MARKET FOR OTHER THERAPIES, BY COUNTRY,
2019–2026 (USD MILLION) 97
9 PEN NEEDLES MARKET, BY MODE OF PURCHASE 98
9.1 INTRODUCTION 99
TABLE 37 PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 99
9.2 RETAIL 99
9.2.1 RETAIL PURCHASES OF PEN NEEDLES TO WITNESS HIGH GROWTH IN THE COMING YEARS OWING TO THE GROWING POPULARITY OF ONLINE PURCHASES 99
TABLE 38 PEN NEEDLES MARKET FOR RETAIL PURCHASES, BY COUNTRY,
2019–2026 (USD MILLION) 100
9.3 NON-RETAIL 100
9.3.1 LARGE NUMBER OF NEEDLE-PHOBIC DIABETIC PATIENTS IS SUPPORTING THE GROWTH OF THIS SEGMENT 100
TABLE 39 INDICATIVE LIST OF REGULATIONS 101
TABLE 40 PEN NEEDLES MARKET FOR NON-RETAIL PURCHASES, BY COUNTRY,
2019–2026 (USD MILLION) 102
10 PEN NEEDLES MARKET, BY REGION 103
10.1 INTRODUCTION 104
TABLE 41 PEN NEEDLES MARKET, BY REGION, 2019–2026 (USD MILLION) 104
FIGURE 32 EMERGING COUNTRIES ARE EXPECTED TO WITNESS HIGHER GROWTH OVER THE FORECAST PERIOD 105
10.2 NORTH AMERICA 106
FIGURE 33 NORTH AMERICA: PEN NEEDLES MARKET SNAPSHOT 106
TABLE 42 NORTH AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 107
TABLE 43 NORTH AMERICA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 44 NORTH AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 107
TABLE 45 NORTH AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 108
TABLE 46 NORTH AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 108
10.2.1 US 108
10.2.1.1 The US dominates the global pen needles market 108
FIGURE 34 TOTAL FERTILITY RATE IN THE US POPULATION (1990-2020) 109
TABLE 47 US: KEY MACROINDICATORS 110
TABLE 48 US: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 110
TABLE 49 US: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 110
TABLE 50 US: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 111
TABLE 51 US: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 111
10.2.2 CANADA 111
10.2.2.1 Unfavorable regulatory processes in Canada to restrain the market growth 111
TABLE 52 CANADA: KEY MACROINDICATORS 112
TABLE 53 CANADA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 112
TABLE 54 CANADA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 113
TABLE 55 CANADA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 113
TABLE 56 CANADA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 113
10.3 EUROPE 114
TABLE 57 EUROPE: PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 114
TABLE 58 EUROPE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 114
TABLE 59 EUROPE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 115
TABLE 60 EUROPE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 115
TABLE 61 EUROPE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 115
10.3.1 GERMANY 116
10.3.1.1 High diabetes expenditure and reimbursement for pen needles is expected to drive the market in Germany 116
TABLE 62 GERMANY: KEY MACROINDICATORS 116
TABLE 63 GERMANY: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 117
TABLE 64 GERMANY: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 117
TABLE 65 GERMANY: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 117
TABLE 66 GERMANY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 118
10.3.2 FRANCE 118
10.3.2.1 Favorable health insurance system to drive the pen needles market in France 118
TABLE 67 FRANCE: KEY MACROINDICATORS 118
TABLE 68 FRANCE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 119
TABLE 69 FRANCE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 119
TABLE 70 FRANCE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 119
TABLE 71 FRANCE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 120
10.3.3 UK 120
10.3.3.1 NHS support and access to cost-effective pen needles are likely to drive the market in the UK 120
TABLE 72 UK: KEY MACROINDICATORS 120
TABLE 73 UK: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 121
TABLE 74 UK: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 121
TABLE 75 UK: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 121
TABLE 76 UK: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 122
10.3.4 ITALY 122
10.3.4.1 Regional variation in terms of coverage and benefits to hinder the market growth 122
TABLE 77 ITALY: KEY MACROINDICATORS 122
TABLE 78 ITALY: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 123
TABLE 79 ITALY: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 123
TABLE 80 ITALY: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 123
TABLE 81 ITALY: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 124
10.3.5 SPAIN 124
10.3.5.1 Supportive regulations mandating the use of safety pen needles to boost the growth of the Spanish market 124
TABLE 82 SPAIN: KEY MACROINDICATORS 125
TABLE 83 SPAIN: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 125
TABLE 84 SPAIN: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 125
TABLE 85 SPAIN: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 126
TABLE 86 SPAIN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 126
10.3.6 REST OF EUROPE 126
TABLE 87 ROE: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 88 ROE: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 127
TABLE 89 ROE: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 127
TABLE 90 ROE: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 128
10.4 ASIA PACIFIC 129
FIGURE 35 APAC: PEN NEEDLES MARKET SNAPSHOT 129
TABLE 91 APAC: PEN NEEDLES MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 130
TABLE 92 APAC: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 130
TABLE 93 APAC: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 130
TABLE 94 APAC: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 131
TABLE 95 APAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 131
10.4.1 JAPAN 131
10.4.1.1 High diabetes incidence and supportive reimbursement policies to drive the market growth in Japan 131
TABLE 96 JAPAN: KEY MACROINDICATORS 132
TABLE 97 JAPAN: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 132
TABLE 98 JAPAN: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 132
TABLE 99 JAPAN: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 133
TABLE 100 JAPAN: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 133
10.4.2 CHINA 133
10.4.2.1 Large patient population and healthcare infrastructure improvements to drive the market growth in China 133
TABLE 101 CHINA: KEY MACROINDICATORS 134
TABLE 102 CHINA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 134
TABLE 103 CHINA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 135
TABLE 104 CHINA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 135
TABLE 105 CHINA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 135
10.4.3 AUSTRALIA AND NEW ZEALAND 136
10.4.3.1 Growing geriatric population in Australia and New Zealand to drive the pen needles market 136
TABLE 106 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 136
TABLE 107 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 136
TABLE 108 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 137
TABLE 109 AUSTRALIA AND NEW ZEALAND: PEN NEEDLES MARKET,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION) 137
10.4.4 INDIA 137
10.4.4.1 Healthcare infrastructural improvements and implementation of favorable government initiatives support the market in India 137
TABLE 110 INDIA: KEY MACROINDICATORS 138
TABLE 111 INDIA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 138
TABLE 112 INDIA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 138
TABLE 113 INDIA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 139
TABLE 114 INDIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 139
10.4.5 SOUTH KOREA 139
10.4.5.1 Growing chronic diseases in the geriatric population augments the growth of the pen needles market 139
TABLE 115 SOUTH KOREA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 140
TABLE 116 SOUTH KOREA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 140
TABLE 117 SOUTH KOREA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 140
TABLE 118 SOUTH KOREA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 141
10.4.6 SOUTHEAST ASIA 141
10.4.6.1 Growing awareness about diabetes drives the pen needles market 141
FIGURE 36 GROWING PREVALENCE OF DIABETES IN SOUTHEAST ASIA 141
FIGURE 37 HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018) 142
FIGURE 38 GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION) 142
TABLE 119 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 142
TABLE 120 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 143
TABLE 121 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 143
TABLE 122 SOUTHEAST ASIA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 143
10.4.7 REST OF APAC 144
TABLE 123 ROAPAC: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 144
TABLE 124 ROAPAC: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 144
TABLE 125 ROAPAC: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 144
TABLE 126 ROAPAC: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 145
10.5 LATIN AMERICA 145
TABLE 127 LATIN AMERICA: PEN NEEDLES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 145
TABLE 128 LATIN AMERICA: PEN NEEDLES MARKET, BY TYPE,
2019–2026 (USD MILLION) 145
TABLE 129 LATIN AMERICA: PEN NEEDLES MARKET, BY LENGTH,
2019–2026 (USD MILLION) 146
TABLE 130 LATIN AMERICA: PEN NEEDLES MARKET, BY THERAPY,
2019–2026 (USD MILLION) 146
TABLE 131 LATIN AMERICA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 146
10.5.1 BRAZIL 147
10.5.1.1 Brazil dominates the pen needles market in Latin America 147
TABLE 132 BRAZIL: KEY MACROINDICATORS 147
TABLE 133 BRAZIL: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 134 BRAZIL: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 148
TABLE 135 BRAZIL: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 148
TABLE 136 BRAZIL: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 148
10.5.2 MEXICO 149
10.5.2.1 Increasing incidence of lifestyle-related disorders and rising awareness drive market growth in Mexico 149
TABLE 137 MEXICO: KEY MACROINDICATORS 149
TABLE 138 MEXICO: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 149
TABLE 139 MEXICO: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 150
TABLE 140 MEXICO: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 150
TABLE 141 MEXICO: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 150
10.5.3 REST OF LATIN AMERICA 151
FIGURE 39 HEALTH EXPENDITURE IN LATIN AMERICAN COUNTRIES IN 2018 (% GDP) 151
TABLE 142 ROLA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 151
TABLE 143 ROLA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 152
TABLE 144 ROLA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 152
TABLE 145 ROLA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 152
10.6 MIDDLE EAST AND AFRICA 153
10.6.1 INITIATIVES TO ENHANCE HEALTHCARE ACCESSIBILITY MAY SUPPORT MARKET GROWTH 153
TABLE 146 MEA: PEN NEEDLES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 147 MEA: PEN NEEDLES MARKET, BY LENGTH, 2019–2026 (USD MILLION) 154
TABLE 148 MEA: PEN NEEDLES MARKET, BY THERAPY, 2019–2026 (USD MILLION) 154
TABLE 149 MEA: PEN NEEDLES MARKET, BY MODE OF PURCHASE,
2019–2026 (USD MILLION) 154
11 COMPETITIVE LANDSCAPE 155
11.1 OVERVIEW 155
11.2 KEY PLAYER STRATEGIES 155
11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 156
FIGURE 40 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PEN NEEDLES MARKET 156
11.4 MARKET SHARE ANALYSIS 156
FIGURE 41 PEN NEEDLES MARKET SHARE, BY KEY PLAYER, 2020 157
11.5 COMPANY EVALUATION QUADRANT 158
11.5.1 STARS 158
11.5.2 EMERGING LEADERS 158
11.5.3 PERVASIVE PLAYERS 159
11.5.4 PARTICIPANTS 159
FIGURE 42 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT (2020) 159
11.6 COMPANY EVALUATION QUADRANT FOR START-UPS 160
11.6.1 PROGRESSIVE COMPANIES 160
11.6.2 DYNAMIC COMPANIES 160
11.6.3 STARTING BLOCKS 160
11.6.4 RESPONSIVE COMPANIES 160
FIGURE 43 PEN NEEDLES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020) 161
11.7 COMPANY PRODUCT FOOTPRINT 162
TABLE 150 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET 162
TABLE 151 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY LENGTH 163
TABLE 152 PRODUCT PORTFOLIO ANALYSIS: PEN NEEDLES MARKET, BY THERAPY 164
11.8 COMPANY GEOGRAPHIC FOOTPRINT 165
TABLE 153 GEOGRAPHIC REVENUE MIX: PEN NEEDLES MARKET (2020) 165
11.9 COMPETITIVE INTENSITY 166
11.9.1 EVALUATION PARAMETERS 166
TABLE 154 EVALUATION PARAMETERS & SCORES 166
11.9.2 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY 168
FIGURE 44 SCORING METHODOLOGY FOR COMPETITIVE INTENSITY 168
11.9.3 COMPETITIVE INTENSITY SCORE, BY COMPANY 168
11.9.3.1 Competitive intensity score for BD 168
TABLE 155 COMPETITIVE INTENSITY FOR BD 168
11.9.3.2 Competitive intensity score for Novo Nordisk 169
TABLE 156 COMPETITIVE INTENSITY FOR NOVO NORDISK 169
11.9.3.3 Competitive intensity score for Ypsomed 170
TABLE 157 COMPETITIVE INTENSITY FOR YPSOMED 170
11.9.4 COMPETITIVE INTENSITY MAPPING: BD, NOVO NORDISK, AND YPSOMED 171
FIGURE 45 COMPARISONS OF COMPETITIVE INTENSITY SCORES: BD, NOVO NORDISK, AND YPSOMED 171
FIGURE 46 RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND PEN NEEDLE FOCUS 172
11.9.4.1 Product launches/technological advancements 173
FIGURE 47 BD HAS A HIGHER FOCUS ON INNOVATION FOR ITS PEN NEEDLES BUSINESS 173
11.9.4.2 Promotional/marketing activities 173
FIGURE 48 BD AND NOVO NORDISK SHOWCASE A HIGH FOCUS ON MARKETING & PROMOTIONAL ACTIVITIES 173
11.9.4.3 Sponsorships/donations/education/awareness campaigns 174
FIGURE 49 NOVO NORDISK A/S HAS A HIGH FOCUS ON DIABETES EDUCATION & AWARENESS 174
11.9.4.4 Certifications/accreditations/awards 174
FIGURE 50 BD, NOVO NORDISK, AND YPSOMED EQUALLY EXHIBIT HIGH COMPLIANCE WITH INDUSTRY STANDARDS 174
11.10 COMPETITIVE SCENARIO 175
11.10.1 PRODUCT LAUNCHES 175
TABLE 158 PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021) 175
11.10.2 DEALS 175
TABLE 159 DEALS (JANUARY 2018– JUNE 2021) 175
11.10.3 OTHER DEVELOPMENTS 176
TABLE 160 OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021) 176
12 COMPANY PROFILES 177
12.1 KEY PLAYERS 177
(Business overview, Products offered, Recent developments, MNM view)*
12.1.1 BECTON, DICKINSON AND COMPANY 177
TABLE 161 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 177
FIGURE 51 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 178
12.1.2 NOVO NORDISK A/S 181
TABLE 162 NOVO NORDISK A/S: BUSINESS OVERVIEW 181
FIGURE 52 NOVO NORDISK A/S: COMPANY SNAPSHOT (2020) 182
12.1.3 YPSOMED HOLDING AG 184
TABLE 163 YPSOMED HOLDING AG: BUSINESS OVERVIEW 184
FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2020) 185
12.1.4 B. BRAUN MELSUNGEN AG 187
TABLE 164 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 187
FIGURE 54 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 188
12.1.5 TERUMO CORPORATION 190
TABLE 165 TERUMO CORPORATION: BUSINESS OVERVIEW 190
FIGURE 55 TERUMO CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.6 NIPRO CORPORATION 193
TABLE 166 NIPRO CORPORATION: BUSINESS OVERVIEW 193
FIGURE 56 NIPRO CORPORATION: COMPANY SNAPSHOT (2020) 194
12.1.7 OWEN MUMFORD 195
TABLE 167 OWEN MUMFORD: BUSINESS OVERVIEW 195
12.1.8 ARKRAY 197
TABLE 168 ARKRAY: BUSINESS OVERVIEW 197
12.1.9 ULTIMED 199
TABLE 169 ULTIMED: BUSINESS OVERVIEW 199
12.1.10 HINDUSTAN SYRINGES AND MEDICAL DEVICES 200
TABLE 170 HINDUSTAN SYRINGES AND MEDICAL DEVICES: BUSINESS OVERVIEW 200
12.1.11 MONTMED 201
TABLE 171 MONTMED: BUSINESS OVERVIEW 201
12.1.12 HTL-STREFA 202
TABLE 172 HTL-STREFA: BUSINESS OVERVIEW 202
12.1.13 ALLISON MEDICAL, INC. 204
TABLE 173 ALLISON MEDICAL: BUSINESS OVERVIEW 204
12.1.14 GLUCORX 205
TABLE 174 GLUCORX: BUSINESS OVERVIEW 205
12.1.15 BERPU MEDICAL TECHNOLOGY 206
TABLE 175 BERPU MEDICAL TECHNOLOGY: BUSINESS OVERVIEW 206
12.1.16 ADVACARE PHARMA 207
TABLE 176 ADVACARE PHARMA: BUSINESS OVERVIEW 207
12.1.17 ARTSANA GROUP 208
TABLE 177 ARTSANA GROUP: BUSINESS OVERVIEW 208
12.1.18 PROMISEMED DIABETES CARE 209
TABLE 178 PROMISEMED DIABETES CARE: BUSINESS OVERVIEW 209
12.1.19 TRIVIDIA HEALTH 210
TABLE 179 TRIVIDIA HEALTH: BUSINESS OVERVIEW 210
12.1.20 VOGT MEDICAL VERTRIEB 211
TABLE 180 VOGT MEDICAL VERTRIEB GMBH: BUSINESS OVERVIEW 211
*Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 212
12.2.1 VAN HEEK MEDICAL 212
TABLE 181 VAN HEEK MEDICAL: COMPANY OVERVIEW 212
12.2.2 SIMPLE DIAGNOSTICS 213
TABLE 182 SIMPLE DIAGNOSTICS: COMPANY OVERVIEW 213
12.2.3 IYON 214
TABLE 183 IYON: COMPANY OVERVIEW 214
12.2.4 LINKS MEDICAL PRODUCTS 215
TABLE 184 LINKS MEDICAL PRODUCTS: COMPANY OVERVIEW 215
12.2.5 MHC MEDICAL PRODUCTS 215
TABLE 185 MHC MEDICAL PRODUCTS: COMPANY OVERVIEW 215
13 APPENDIX 216
13.1 DISCUSSION GUIDE 216
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220
13.3 AVAILABLE CUSTOMIZATIONS 222
13.4 RELATED REPORTS 222
13.5 AUTHOR DETAILS 223

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127